These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20822340)

  • 1. Bluetongue vaccination in Europe.
    Zientara S; MacLachlan NJ; Calistri P; Sanchez-Vizcaino JM; Savini G
    Expert Rev Vaccines; 2010 Sep; 9(9):989-91. PubMed ID: 20822340
    [No Abstract]   [Full Text] [Related]  

  • 2. Bluetongue vaccines.
    Noad R; Roy P
    Vaccine; 2009 Nov; 27 Suppl 4():D86-9. PubMed ID: 19837295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bluetongue vaccines: the past, present and future.
    Bhanuprakash V; Indrani BK; Hosamani M; Balamurugan V; Singh RK
    Expert Rev Vaccines; 2009 Feb; 8(2):191-204. PubMed ID: 19196199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination against bluetongue serotype 8 in the Netherlands].
    Kuijk H; Jansen M; Moulin V; Makoschey B
    Tijdschr Diergeneeskd; 2008 Dec; 133(23):1006-9. PubMed ID: 19133439
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.
    Bréard E; Belbis G; Hamers C; Moulin V; Lilin T; Moreau F; Millemann Y; Montange C; Sailleau C; Durand B; Desprat A; Viarouge C; Hoffmann B; de Smit H; Goutebroze S; Hudelet P; Zientara S
    Vaccine; 2011 Mar; 29(13):2495-502. PubMed ID: 21256877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal disease. Exotic disease of farm animals tests Europe's responses.
    Enserink M
    Science; 2008 Feb; 319(5864):710-1. PubMed ID: 18258867
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Detection of bluetongue virus genome after vaccination with an inactivated vaccine.
    Eschbaumer M; Wäckerlin R; Hoffmann B; Beer M
    Vaccine; 2010 Jan; 28(4):881-2. PubMed ID: 19925907
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of an inactivated combined vaccine for protection of cattle against lumpy skin disease and bluetongue viruses.
    Es-Sadeqy Y; Bamouh Z; Ennahli A; Safini N; El Mejdoub S; Omari Tadlaoui K; Gavrilov B; El Harrak M
    Vet Microbiol; 2021 May; 256():109046. PubMed ID: 33780805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.
    Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A
    Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the humoral immune response in adult dairy cattle three years after vaccination with a bluetongue serotype 8 inactivated vaccine.
    Oura CA; Edwards L; Batten CA
    Vaccine; 2012 Jan; 30(2):112-5. PubMed ID: 22067262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines.
    Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD
    Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potency and efficacy of inactivated bluetongue virus vaccines.
    Stevens DR; Stott J; Osburn BI; Giles R; Wiesehahn GP; Barber TL
    Prog Clin Biol Res; 1985; 178():649-52. PubMed ID: 2989914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant vaccines against bluetongue virus.
    Calvo-Pinilla E; Castillo-Olivares J; Jabbar T; Ortego J; de la Poza F; Marín-López A
    Virus Res; 2014 Mar; 182():78-86. PubMed ID: 24287057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses and protective efficacy of binary ethylenimine (BEI)-inactivated bluetongue virus vaccines in sheep.
    Ramakrishnan MA; Pandey AB; Singh KP; Singh R; Nandi S; Mehrotra ML
    Vet Res Commun; 2006 Nov; 30(8):873-80. PubMed ID: 17139537
    [No Abstract]   [Full Text] [Related]  

  • 17. Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines.
    González JM; Figueras L; Ortega ME; Lozano M; de Arcaute MR; Royo R; Cebrián LM; Ferrer LM; Fariñas F; de Jalón JA; De las Heras M
    Vet Rec; 2010 Jun; 166(24):757-8. PubMed ID: 20543167
    [No Abstract]   [Full Text] [Related]  

  • 18. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep.
    Oura CA; Wood JL; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Floyd T; Simmons H; Batten CA
    Vaccine; 2009 Dec; 27(52):7326-30. PubMed ID: 19786141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines for bluetongue and other orbiviruses from a regulatory viewpoint.
    Strating A
    Prog Clin Biol Res; 1985; 178():627-9. PubMed ID: 2989911
    [No Abstract]   [Full Text] [Related]  

  • 20. Current and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations.
    Feenstra F; van Rijn PA
    Crit Rev Microbiol; 2017 Mar; 43(2):142-155. PubMed ID: 27800699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.